Company intelligence / Profile preview

David Van Sickle

Madison, Wisconsin, USAdavidvansickle.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Propeller Health developed FDA-cleared and EMEA-approved digital health solutions that improve clinical outcomes in asthma and COPD. The technology has been validated in over thirty peer-reviewed publications, including randomized controlled trials demonstrating improved medication adherence and reduced exacerbations. The company commercialized multiple device/software products globally before being acquired by ResMed in 2019 for $225M.

Therapeutic areas: Pulmonology
Modalities: DeviceSoftware (Digital therapeutic)Combination product (Device + pharmaceutical)
Industry: Digital Health Medical Devices

Partnerships

Novartis (co-packaged pharmaceutical + digital product approved in EMEA)WalgreensDignity Healthvarious PBMs/pharmacies/pharma companies

Beyond the preview

Go deeper on David Van Sickle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on David Van Sickle.

Explore the full profile